Ma C - Search Results

1

Early Assessment Window for Predicting Breast Cancer Neoadjuvant Therapy using Biomarkers, Ultrasound, and Diffuse Optical Tomography.

Zhu Q, Ademuyiwa FO, Young C, Appleton C, Covington MF, Ma C, Sanati S, Hagemann IS, Mostafa A, Uddin KMS, Grigsby I, Frith AE, Hernandez-Aya LF, Poplack SS. Zhu Q, et al. Among authors: ma c. Breast Cancer Res Treat. 2021 Aug;188(3):615-630. doi: 10.1007/s10549-021-06239-y. Epub 2021 May 10. Breast Cancer Res Treat. 2021. PMID: 33970392 Free PMC article.

2

Neoadjuvant endocrine therapy for locally advanced breast cancer.

Ma CX, Ellis MJ. Ma CX, et al. Semin Oncol. 2006 Dec;33(6):650-6. doi: 10.1053/j.seminoncol.2006.08.013. Semin Oncol. 2006. PMID: 17145344 Review.

3

Letrozole in the neoadjuvant setting: the P024 trial.

Ellis MJ, Ma C. Ellis MJ, et al. Among authors: ma c. Breast Cancer Res Treat. 2007;105 Suppl 1(Suppl 1):33-43. doi: 10.1007/s10549-007-9701-x. Epub 2007 Oct 3. Breast Cancer Res Treat. 2007. PMID: 17912634 Free PMC article. Clinical Trial.

4

Femara and the future: tailoring treatment and combination therapies with Femara.

Ellis M, Ma C. Ellis M, et al. Among authors: ma c. Breast Cancer Res Treat. 2007;105 Suppl 1(Suppl 1):105-15. doi: 10.1007/s10549-007-9697-2. Epub 2007 Oct 3. Breast Cancer Res Treat. 2007. PMID: 17912640 Free PMC article. Review.

5

Predicting endocrine therapy responsiveness in breast cancer.

Ma CX, Sanchez CG, Ellis MJ. Ma CX, et al. Oncology (Williston Park). 2009 Feb;23(2):133-42. Oncology (Williston Park). 2009. PMID: 19323294 Free article. Review.

6

Neoadjuvant endocrine therapy for breast cancer.

Chawla JS, Ma CX, Ellis MJ. Chawla JS, et al. Surg Oncol Clin N Am. 2010 Jul;19(3):627-38. doi: 10.1016/j.soc.2010.04.004. Surg Oncol Clin N Am. 2010. PMID: 20620931 Review.

7

Neoadjuvant endocrine therapy in primary breast cancer: indications and use as a research tool.

Chia YH, Ellis MJ, Ma CX. Chia YH, et al. Among authors: ma cx. Br J Cancer. 2010 Sep 7;103(6):759-64. doi: 10.1038/sj.bjc.6605845. Epub 2010 Aug 10. Br J Cancer. 2010. PMID: 20700118 Free PMC article. Review.

8

Neoadjuvant chemotherapy is associated with improved survival compared with adjuvant chemotherapy in patients with triple-negative breast cancer only after complete pathologic response.

Fisher CS, Ma CX, Gillanders WE, Aft RL, Eberlein TJ, Gao F, Margenthaler JA. Fisher CS, et al. Ann Surg Oncol. 2012 Jan;19(1):253-8. doi: 10.1245/s10434-011-1877-y. Epub 2011 Jul 2. Ann Surg Oncol. 2012. PMID: 21725686 Free PMC article.

9

Molecular profiling of triple negative breast cancer.

Ma CX, Luo J, Ellis MJ. Ma CX, et al. Breast Dis. 2010;32(1-2):73-84. doi: 10.3233/BD-2010-0309. Breast Dis. 2010. PMID: 21778575 Review.

10

Phase II trial of temsirolimus in patients with metastatic breast cancer.

Fleming GF, Ma CX, Huo D, Sattar H, Tretiakova M, Lin L, Hahn OM, Olopade FO, Nanda R, Hoffman PC, Naughton MJ, Pluard T, Conzen SD, Ellis MJ. Fleming GF, et al. Among authors: ma cx. Breast Cancer Res Treat. 2012 Nov;136(2):355-63. doi: 10.1007/s10549-011-1910-7. Epub 2012 Jan 13. Breast Cancer Res Treat. 2012. PMID: 22245973 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17,247 results

Search Page